Topical n-docosanol for management of recurrent herpes labialis.

@article{Treister2010TopicalNF,
  title={Topical n-docosanol for management of recurrent herpes labialis.},
  author={Nathaniel Simon Treister and Sook-bin Woo},
  journal={Expert opinion on pharmacotherapy},
  year={2010},
  volume={11 5},
  pages={853-60}
}

• Nathaniel Simon Treister, Sook-bin Woo
• Published 2010 in Expert opinion on pharmacotherapy
• DOI:10.1517/14656561003691847

IMPORTANCE OF THE FIELD Recurrent herpes labialis (RHL) is a significant disorder with social and health consequences that affects upwards of 20 - 40% of the adult population. Docosanol is the only FDA-approved topical agent that is available over the counter for management of RHL. Its mechanism of action is unique compared with other available antiviral agents. AREAS COVERED IN THIS REVIEW The authors conducted a comprehensive search of the published preclinical and clinical literature on… CONTINUE READING

Save

Watch Paper

Cite

View on PubMed